NAARDEN, P7
Allocation by class
Portfolio Concentration
Top 3 weight
62.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 44.09M
Full voting authority
0.00
shares
Joint voting authority
44.09M
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 9.20M | SH | $294.46M 40.77% | 0.00 | 9.20M | 0.00 |
DYNE THERAPEUTICS INCDFND | COM | 4.64M | SH | $84.20M 11.66% | 0.00 | 4.64M | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 4.12M | SH | $73.45M 10.17% | 0.00 | 4.12M | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 9.63M | SH | $65.60M 9.08% | 0.00 | 9.63M | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 3.23M | SH | $65.59M 9.08% | 0.00 | 3.23M | 0.00 |
DAMORA THERAPEUTICS INCDFND | COM NEW | 2.44M | SH | $63.22M 8.75% | 0.00 | 2.44M | 0.00 |
CRESCENT BIOPHARMA INC.DFND | COM | 1.68M | SH | $30.82M 4.27% | 0.00 | 1.68M | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 2.81M | SH | $21.48M 2.97% | 0.00 | 2.81M | 0.00 |
BICYCLE THERAPEUTICS PLCDFND | SPONSORED ADS | 3.47M | SH | $16.09M 2.23% | 0.00 | 3.47M | 0.00 |
ENGENE HOLDINGS INCDFND | W EXP 10/31/2028 | 2.88M | SH | $7.28M 1.01% | 0.00 | 2.88M | 0.00 |